and the Institut Pasteur
awarded the Sanofi - Institut Pasteur awards
for the third consecutive year.Four internationally renowned researchers were honored today for their work carried out in two major fields concerning world health: neglected tropical diseases and immunology.
Created in 2012, these awards encourage innovation and scientific excellence in the service of health. In 2014, the program set aside a total of 300.000 euros to reward and encourage research. In this third edition, four researchers and their projects were selected from among approximately 80 scientists from around the world:
· Doctor Priscille Brodin
, Research Director at Inserm within the Center of Infection and Immunology of Lille - CIIL (joint structure of the CNRS, the Inserm, the Institut Pasteur in Lille and the University of Lille) for her research on tuberculosis and Buruli ulcer.
· Doctor Nadine Laguette
, researcher at the CNRS, for her research on the role of the SAMHD1 protein in infections caused by the HIV.
· Professor Jean-Laurent Casanova
, Professor at the Rockefeller University and Associate Professor at the Necker Hospital for Sick Children, for his research on genetics and infectious diseases, particularly in children.
· Professor Etienne Pays
, a researcher at the Université Libre de Bruxelles, for his research on trypanosomal diseases, notably human African trypanosomiasis, commonly known as sleeping sickness.
The awardees received the awards during a ceremony held today at Sanofi’s headquarters, in the company of Serge Weinberg, Chairman of the Board and CEO of Sanofi, and Professor Christian Bréchot, President of the Institut Pasteur.
“For this third edition, the Institut Pasteur is once again proud to join forces with Sanofi, its long-standing and privileged partner, in order to reward four top-level researchers " stated Prof. Christian Bréchot, President of the Institut Pasteur. “This year, we chose to encourage scientists whose careers fall within all three categories, from Junior to Senior. Supporting experienced researchers is as much about recognizing their major contributions to world health as it is in honoring eminent professionals, their vision and contributions within the scientific community. Rewarding the youngest researchers, however, is to believe in the future, which must also be a top priority.”
Elias Zerhouni, President, Global Research & Development of Sanofi said "These Awards are the natural continuation of the historic collaboration we have developed with the Institut Pasteur and we are proud to pursue our innovation-based alliance with its researchers. Public health requirements are constantly changing, it is therefore essential that we never stop encouraging innovation. Through these Awards, we are showing our commitment and our support for research and discoveries which will one day be able to prevent diseases or provide better treatments against diseases for those who need them.”